Article Text

PDF
Application of Gleason analogous grading system and flow cytometry DNA analysis in a novel knock-in mouse prostate cancer model
  1. G Wu1,2,
  2. Lei Yu1,
  3. L Wang1,
  4. H Wang1,
  5. J W Xuan2
  1. 1Department of Urology, Xijing Hospital, the Fourth Military Medical University, Xi’an, China
  2. 2Department of Surgery, University of Western Ontario, London, Ontario, Canada
  1. Correspondence to:
 Dr G Wu and Dr H Wang
 Department of Urology, Xijing Hospital, the Fourth Military Medical University, Xi’an, China, 710032; wuguojun{at}fmmu.edu.cn; dusxjhw{at}fmmu.edu.cn

Abstract

Objective: A new knock-in mouse adenocarcinoma prostate model (KIMAP) was established, which showed a close to human kinetics of tumour development. This study used a new mouse histological grading system similar to the human Gleason grading system and flow cytometry DNA analysis to measure and compare the new KIMAP model with human CaP and transgenic mouse adenocarcinoma prostate (TGMAP) model.

Methods: According to heterogeneity of the clinical standard for prostate cancer diagnosis, a close to human mouse standard for histological grading and scoring system, Gleason analogous grading system, was established in this study. Sixty KIMAP and 48 TGMAP prostate cancer samples were measured and compared with human CaP. Flow cytometry DNA analysis was performed on malignant prostate tissues obtained from both TGMAP and KIMAP models.

Results: Mice with CaP from KIMAP (n = 60) and TGMAP (n = 48) models showed a different distribution of histological scores (p = 0.000). KIMAP mice showed higher percentage (53.3%) of compound histological score rate than TGMAP (25%), but closer to the human clinical average (50%), which showed significant correlation with age (p = 0.001), while TGMAP mice showed unbalanced and random score distribution in all age groups. Flow cytometry analyses showed that most tumour tissues in KIMAP were diploid, analogous to the human condition, while all the TGMAP mice showed aneuploid tumours.

Conclusions: Results of this study further show that KIMAP, a new generation of murine prostate cancer model, could be used as a supplementary model in addition to the currently widely used transgenic models.

  • KIMAP, knock-in mouse adenocarcinoma prostate
  • TGMAP, transgenic mouse adenocarcinoma prostate
  • PSA, prostrate specific antigen
  • prostate neoplasms
  • knock-in mouse model

Statistics from Altmetric.com

Footnotes

  • Conflict of interests: G J Wu has been paid by the Fourth Military Medical University for running educational programmes and financial support for attendance at scientific meetings.

  • The first three authors contributed equally to this work.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.